Nanofilm Technologies (MZH) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
21 Oct, 2026Executive summary
Revenue rose 29.6% year-over-year to S$107.2 million, with growth across all business units led by Advanced Materials and Industrial Equipment.
PATMI returned to profit at S$1.6 million, reversing a S$3.7 million loss in 1H2024; net profit after tax was S$1.4 million.
Adjusted EBITDA increased 46.1% to S$24.4 million, reflecting improved operational performance.
Financial highlights
Gross profit rose 26.4% to S$34.9 million; gross profit margin declined to 32.6% from 33.5% due to product mix and higher costs from new projects.
Operating cash flow was S$20.1 million; net cash used in investing activities was S$33.9 million.
Cash and cash equivalents were S$95.1 million at 30 June 2025, down from S$110.2 million at year-end 2024.
Interim dividend of S$0.0033 per share, or S$2.1 million in total, declared, payable 5 September 2025.
Outlook and guidance
Consumer demand is expected to become more balanced through 2025 as projects ramp up and NPI projects commence; Industrial growth momentum is expected to continue into 2H2025.
IEBU expects equipment deliveries and stable after-sales revenue; NFBU anticipates growth from higher programme allocations and new strategic programmes.
Sydrogen has pilot shipments of air-cooled fuel cell systems underway in China; SydroPEARL electrolyser coating launch strengthens its hydrogen value-chain position.
FY2025 revenue is expected to be driven by Advanced Materials Consumer, European business growth and new products; capital expenditure remains disciplined.
Latest events from Nanofilm Technologies
- Capacity investments and segment momentum underpin growth plans amid supply-chain disruption.MZH
Q4 2021 TU - Record FY2021 results and expanded capacity set the stage for FY2022 growth.MZH
H2 2021 - Revenue grew 24.2%, while startup and NPI costs pressured profit and margins.MZH
H1 2021 - 2H recovery lifted earnings and margins, underpinning conditional FY2024 growth expectations.MZH
H2 2023 - Headwinds cut FY2022 results, while expansion and the 2025 targets remained on track.MZH
H2 2022 - Revenue fell 34.4% as consumer weakness drove a H1 loss; 2H revenue is expected higher.MZH
H1 2023 - FY2025 revenue rose 20% and PAT 58%, led by AMBU growth and an IEBU recovery.MZH
H2 2025 - Revenue grew 13%, adjusted EBITDA rose 61.4%, and FY2024 growth is expected.MZH
H1 2024 - Revenue rose 15% and adjusted EBITDA 31%, supported by growth and global expansion.MZH
H2 2024